TRT does not raise cardiovascular risks in hypogonadism

15 Jul 2022

According to a new study, published in The Lancet Healthy Longevity, testosterone therapy in men with hypogonadism does not increase their risk of cardiovascular complications. This is in line with existing advice from the European Medicines Agency and the UK Society for Endocrinology’s treatment guidelines.

Medical Academic

Related Topics

Steroid and Steroidogenesis

Share this story